A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
about
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cellsThe lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cellsThe effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancerLysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiationInhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.Sarcoidosis in black women in the United States: data from the Black Women's Health StudyAnalysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.Association of the G473A polymorphism and expression of lysyl oxidase with breast cancer risk and survival in European women: a hospital-based case-control studyRecombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenograftsBlimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.Lysyl oxidase polymorphisms and susceptibility to osteosarcoma.Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.Lysyl oxidase, extracellular matrix remodeling and cancer metastasisA function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.Variation in the lysyl oxidase (LOX) gene is associated with keratoconus in family-based and case-control studies.Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes.Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.Lysyl oxidase isoforms in gastric cancer.Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.Comparative distribution of Lysyl Oxidase (G473A) and NQO1 (C609T) polymorphism among tea-garden workers (habitual chewers of betel quid) of Darjeeling district and Kolkata city of West Bengal.Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptideCharacterization of recombinant lysyl oxidase propeptide.Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population.Lysyl oxidase polymorphisms and ischemic stroke--a case control study.Functional importance of lysyl oxidase family propeptide regions.Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling.Lysyl oxidase genetic variants and the prognosis of glioma.Association of Lysyl oxidase (LOX) Polymorphisms with the Risk of Keratoconus in an Iranian Population.Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners
P2860
Q24301022-5259C819-2CE5-451B-8A7C-17E69A029A1BQ24307235-5F1BE46F-04CC-419D-9478-8B8AEAB193F4Q28274238-C22DCD50-DBB8-47D1-9498-EB4A067FBAE4Q28587970-C175540C-BADF-4B88-A69C-3DCD87044968Q30009534-DCF8E3D0-F126-43DF-91AA-38F9C715A630Q30409213-A7F040D1-0E38-49B1-930E-A8BB5F6D8B0DQ33292171-55EA0395-9E8D-42F9-A7F9-2A40317C52E1Q33623252-D4467111-D43E-4153-AFA0-0C19E22F2C5DQ33867402-95AD7FBA-27D9-4602-9AF9-BF4F19D76F21Q34070903-C457D0A6-D242-48BC-A80E-3E8C6448F5AAQ34170606-96BFC75F-BF96-4281-8969-B7B5E3F5FB98Q34206164-FE21E08C-DBE2-418A-948B-23FCB1948B9EQ34355294-2DAEC579-0B88-4C8B-9781-7D0489DB147EQ34388063-652E7BDD-3E67-4CDB-9255-8E466044FA4AQ34704924-5BC0B506-5450-4B6A-A905-9A679A247AB7Q35144992-81E28C22-27BB-4128-9158-27EF88B9D80AQ36265638-2BE9D04C-D686-4E37-A25C-1F17F134A5C2Q36284915-64A4E36D-A49C-4557-9C8D-0D9E13C30353Q36962901-BE395D8B-87C1-407E-A278-27214404E0F0Q37140041-CED40089-C6AD-42E2-9A92-6D9217D3F420Q37532942-D046DE68-AB3C-4AF2-AD43-231E494E1B67Q37983798-15AE38D0-7B7E-4FF2-AB03-3367C842566DQ38723997-E08AA79B-A0ED-4AD0-A44D-34C0EE0B8ACDQ38937873-DF80453E-187A-4FE3-8AEE-EEC57E7A0DC1Q38989588-25DA212E-6465-423D-B77C-C7C3B80176B0Q40251892-1DD71F25-FF48-4AF2-8E1C-510908B28B8BQ41855622-7D6E6275-0959-4ACF-9897-FA83EBB98117Q41898229-D0812F2A-6AAA-4131-9302-5976C4CF4033Q42853848-1B05BCE9-2C12-4F8E-9189-685D34BAE816Q43469688-E60EC037-B138-40AF-9F1B-806925219816Q44479196-31D964A0-8016-49C4-85B5-2B5765B3DC73Q47584936-8AEC9A71-B4A2-4C39-97C8-980451D93A98Q49277335-2D8FC101-5F39-4334-A918-C2649C700A9FQ50916015-8CBF04EA-F9EF-481F-8473-82A20DAD8FBBQ54224045-832F4964-2066-4DCD-BE51-6AFDE683A1D9Q58799743-AB5019D1-0A8E-4F06-9CE4-BDE150AD4DE4
P2860
A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@en
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@nl
type
label
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@en
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@nl
prefLabel
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@en
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@nl
P2093
P2860
P50
P1433
P1476
A loss-of-function polymorphis ...... he LOX gene and breast cancer.
@en
P2093
Chengyin Min
Douglas B Spicer
Gail E Sonenshein
Siddharth R Vora
Yingshe Zhao
P2860
P304
P356
10.1158/0008-5472.CAN-08-4818
P407
P577
2009-08-04T00:00:00Z